Abstract
Protein aggregation is commonly observed phenomenon occurring during production of recombinant proteins in genetically engineered organisms over-expressing foreign genes. Aggregation of such recombinant proteins often leads to the formation of insoluble protein clusters named inclusion bodies (IBs). Although usually considered as waste by-products of protein production, over the last decade, this general misconception has been questioned by various studies. Gradual understanding of the structural, molecular and physiological features has revealed promising potential of these so far undesirable cellular products. In the present review we summarize basic characteristics of IBs, their use in antimicrobial peptides production and in various biotechnological fields, including tissue engineering, drug delivery and biocatalysis.
Highlights
Biotechnology is a conquering and extremely dynamically developing area, which applications are so wide that practically nowadays every industry uses biotechnology in some form
Aggregation of such recombinant proteins often leads to the formation of insoluble protein clusters named inclusion bodies (IBs)
In the present review we summarize basic characteristics of IBs, their use in antimicrobial peptides production and in various biotechnological fields, including tissue engineering, drug delivery and biocatalysis
Summary
Received 4. 12. 2019 Revised 5. 2. 2020 Accepted 19. 2. 2020 Published 1. 6. 2020. Protein aggregation is commonly observed phenomenon occurring during production of recombinant proteins in genetically engineered organisms over-expressing foreign genes. Protein aggregation is commonly observed phenomenon occurring during production of recombinant proteins in genetically engineered organisms over-expressing foreign genes. Aggregation of such recombinant proteins often leads to the formation of insoluble protein clusters named inclusion bodies (IBs). Usually considered as waste by-products of protein production, over the last decade, this general misconception has been questioned by various studies. Gradual understanding of the structural, molecular and physiological features has revealed promising potential of these so far undesirable cellular products. In the present review we summarize basic characteristics of IBs, their use in antimicrobial peptides production and in various biotechnological fields, including tissue engineering, drug delivery and biocatalysis
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Microbiology, Biotechnology and Food Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
